-
1Academic Journal
المؤلفون: Mauricio A. Villavicencio, MD, Selena S. Li, MD, Ann Marie Leifer, NP, Jenna L. Gustafson, RN, Asishana Osho, MD, Stanley Wolfe, MD, Yuval Raz, MD, Jason Griffith, MD, PhD, Isabel Neuringer, MD, Emily Bethea, MD, Thais Gift, RPh, Georgina Waldman, RPh, Todd Astor, MD, Nathaniel B. Langer, MD, Raymond T. Chung, MD
المصدر: JTCVS Open, Vol 14, Iss , Pp 602-614 (2023)
مصطلحات موضوعية: lung transplantation, hepatitis C, outcomes, antivirals, Diseases of the circulatory (Cardiovascular) system, RC666-701, Surgery, RD1-811
وصف الملف: electronic resource
-
2Report
المساهمون: Raymond T. Chung, MD, Director of Hepatology
المصدر: Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
-
3Report
المساهمون: Raymond T. Chung, MD, Director, Hepatology, Massachusetts General Hospital
المصدر: Use of Direct-acting Antiviral Therapy to Prevent Spread of HCV Infection for Patients Receiving a HCV Positive Kidney Transplant as a HCV Negative Recipient
-
4Report
المؤلفون: Merck Sharp & Dohme LLC
المساهمون: Raymond T. Chung, MD, Director of Hepatology
المصدر: A Proof of Concept Study for Preemptive Treatment With Grazoprevir and Elbasvir in Donor HCV-positive to Recipient HCV-negative Cardiac Transplant
-
5Report
المساهمون: Raymond T. Chung, MD, Director of Hepatology
المصدر: Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers